AMANDA FELLIN: Open Payments
NPI 1851986996 · KING OF PRUSSIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,358 in 171 payments from 18 companies in 2025. Trend: 2023 $904 · 2024 $2,906 · 2025 $4,358
Food & beverage: $4,258Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 56 | $1,568 |
| LEO Pharma Inc. | 8 | $552 |
| Novartis Pharmaceuticals Corporation | 11 | $432 |
| ABBVIE INC. | 20 | $319 |
| UCB, Inc. | 9 | $258 |
| GENZYME CORPORATION | 7 | $243 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $235 |
| PFIZER INC. | 6 | $167 |
| Galderma Laboratories, L.P. | 17 | $160 |
| E.R. Squibb & Sons, L.L.C. | 6 | $115 |
Products named: TREMFYA, ADBRY, COSENTYX, DUPIXENT, Bimzelx, CIBINQO, SKYRIZI, RINVOQ.
Industry payments across PA — which companies pay providers there.
